VE202 in Patients With Mild-to-Moderate Ulcerative Colitis
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202 in Patients With Mild-to-Moderate Ulcerative Colitis Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202in Patients With Mild-to-Moderat ...
Study of VE202 in Patients with Ulcerative Colitis
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202 in Patients with Mild-to-Moderate Ulcerative Colitis Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202in Patients with Mild-to-Moderat ...
Product Name: VE202 Product Code: VE202 INN or Proposed INN: Not applicable Other descriptive name: JNJ-64841829 INN or Proposed INN: Not applicable Other descriptive name: JNJ-64841842 INN or Proposed INN: Not applicable Other descriptive name: JNJ-64841855 INN or Proposed INN: Not applicable Other descriptive name: JNJ-64841894 INN or Proposed INN: Not applicable Other descriptive name: JNJ-64841907 INN or Proposed INN: Not applicable Other descriptive name: JNJ-64841920 INN or Proposed INN: Not applicable Other descriptive name: JNJ-64841933 INN or Proposed INN: Not applicable Other descriptive name: JNJ-64841946 Product Name: VE202 Product Code: VE202 INN or Proposed INN: Not applicable Other descriptive name: JNJ ...
Study of VE202 in Patients with Ulcerative Colitis
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202 in Patients with Mild-to-Moderate Ulcerative Colitis Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202in Patients with Mild-to-Moderat ...
Product Name: VE202 Product Code: VE202 INN or Proposed INN: Not applicable Other descriptive name: JNJ-72537634 Product Name: VE202 Product Code: VE202 INN or Proposed INN: Not applicable Other descriptive name: JNJ ...
Vedanta Biosciences, Inc.
NULL
Authorised-recruitment may be ongoing or finished
Female: yes Male: yes
100
Phase 2
United States;Czechia;Hungary;Poland;Ukraine;Lithuania;Russian Federation;Netherlands